Nelsen Robert's Form 4 filing
DA32 Life Science Tech Acquisition Corp. (DALS) · filed Aug 3, 2021
- Accession no.
- 0000899243-21-031417
- Filed
- Aug 3, 2021, 9:06 PM ET
- Trade date
- Jul 30, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $16.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nelsen RobertCIK 0001219042 | 10% Owner |
| Gillis StevenCIK 0001229592 | 10% Owner |
| Burow KristinaCIK 0001569248 | 10% Owner |
| ARCH Venture Fund XI, L.P.CIK 0001831802 | 10% Owner |
| ARCH Venture Partners XI, L.P.CIK 0001847567 | 10% Owner |
| ARCH Venture Partners XI, LLCCIK 0001847601 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2021 | Class A Common Stock | PPurchaseAcquired | +1,600,000 | $10.00 | +$16,000,000 | 1,600,000 | Direct | Duplicate filing |
| Jul 30, 2021 | Class A Common Stock | JOtherAcquired | +650,000 | $10.00 | +$6,500,000 | 2,250,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
See Exhibit 99.1 - Joint Filer Information, which is incorporated herein by reference and describes in further detail the relationships of the Reporting Persons to the Issuer. Henrikki Harsu, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24.1, 24.2, 24.3, 24.4, 24.5 and 24.6 to a Form 3 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on July 27, 2021 by ARCH Venture Fund XI, L.P., ARCH Venture Partners XI, L.P., ARCH Venture Partners XI, LLC, Kristina Burow, Robert Nelsen and Steven Gillis.